A recent study published in the American Journal of Obstetrics and Gynecology has found a link between AMH levels and IVF success rates.
Through their research, clinicians at Brown University have discovered that patients with a higher level of the Anti-Müllerian hormone (AMH) in their blood were able to produce more eggs for IVF than those with lower levels of AMH. Fertility specialists believe the ability to detect AMH levels can better assist doctors in the individual treatment of IVF patients (source: BioNews).
In vitro fertilization involves stimulating a woman's reproductive system in order to produce eggs that can then be inseminated outside of the body and returned to the uterus. Oftentimes, IVF treatments involve the use of fertility drugs in order to assist a woman with egg production, which in worst case scenarios, can be high risk treatments that involve overmedication, ovarian hyperstimulation, and multiple pregnancies. The Brown University studies show the efforts on behalf of fertility researchers as they work to discover the most efficient treatments for individual patients, which we strongly support here at New Hope through our Natural IVF and Mini-IVF protocols.
The recent findings by the medical professionals at Brown University are exciting developments that, if confirmed by more research, will only better serve IVF doctors in the individual treatments of patients. This research underlines the importance of treating every potential mother on a case-by-case basis in order to increase success rates and decrease overmedication and other health risks for both mother and child.
More details on this study can be found here.